Targeted inhibition of KCa3.1 attenuates TGF-β-induced reactive astrogliosis through the Smad2/3 signaling pathway.
about
Reactive astrocytes and therapeutic potential in focal ischemic strokeThe Potassium Channel KCa3.1 Represents a Valid Pharmacological Target for Astrogliosis-Induced Neuronal Impairment in a Mouse Model of Alzheimer’s DiseaseTocotrienol alleviates inflammation and oxidative stress in a rat model of spinal cord injury via suppression of transforming growth factor-β.Human lung myofibroblast TGFβ1-dependent Smad2/3 signalling is Ca(2+)-dependent and regulated by KCa3.1 K(+) channelsEndogenous repair signaling after brain injury and complementary bioengineering approaches to enhance neural regenerationMegalencephalic leukoencephalopathy with subcortical cysts protein-1 regulates epidermal growth factor receptor signaling in astrocytes.Myelin phagocytosis by astrocytes after myelin damage promotes lesion pathology.The potassium channel KCa3.1 constitutes a pharmacological target for astrogliosis associated with ischemia stroke.KCa3.1 Inhibition Switches the Astrocyte Phenotype during Astrogliosis Associated with Ischemic Stroke Via Endoplasmic Reticulum Stress and MAPK Signaling Pathways.Astrocytes from the brain microenvironment alter migration and morphology of metastatic breast cancer cells.Neuroprotective Effects of Direct Intrathecal Administration of Granulocyte Colony-Stimulating Factor in Rats with Spinal Cord Injury.RGMa mediates reactive astrogliosis and glial scar formation through TGFβ1/Smad2/3 signaling after stroke.
P2860
Q28393830-4213F8D5-B3AD-4AA1-90F0-8CF20349A6BFQ28468424-FC8A7E90-ED81-4E1F-9C9E-CE5261555B9BQ33847125-62645C9C-F647-4606-903C-6BB2043375B1Q35232951-8D78F866-417F-4E22-B81D-FC3DFBF5CB20Q35600150-48A410E9-A97A-4A8B-B701-3E5EF7FEAE43Q38791524-E6567BDB-9015-48D5-8B63-A8D02DBE4C0DQ39070347-76A55D25-DB90-45F3-B36F-3EDB426B4C7DQ42689886-50496538-45C5-4623-ABB9-AB3F188E6C33Q42694633-B154C22A-CA59-43C2-A00A-C52F6DAE664CQ47813084-043C524C-D807-4937-8BBC-F58B0592505AQ48077973-7AB838F2-16A1-4E2F-9D84-726004D38F10Q49357667-82028342-84A6-4F16-9D73-557ABEAE13A4
P2860
Targeted inhibition of KCa3.1 attenuates TGF-β-induced reactive astrogliosis through the Smad2/3 signaling pathway.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Targeted inhibition of KCa3.1 ...... the Smad2/3 signaling pathway.
@ast
Targeted inhibition of KCa3.1 ...... the Smad2/3 signaling pathway.
@en
type
label
Targeted inhibition of KCa3.1 ...... the Smad2/3 signaling pathway.
@ast
Targeted inhibition of KCa3.1 ...... the Smad2/3 signaling pathway.
@en
prefLabel
Targeted inhibition of KCa3.1 ...... the Smad2/3 signaling pathway.
@ast
Targeted inhibition of KCa3.1 ...... the Smad2/3 signaling pathway.
@en
P2093
P2860
P356
P1476
Targeted inhibition of KCa3.1 ...... the Smad2/3 signaling pathway.
@en
P2093
Hongzhuan Chen
P2860
P356
10.1111/JNC.12710
P407
P577
2014-03-27T00:00:00Z